CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 142 enrolled
Drug / intervention
Bupivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01272921
NCT01272921Phase 4Completed
CompareCT.gov

A Dose Response Study for Duration of Analgesia Using Bupivacaine and Ropivacaine for Infragluteal Parabiceps Sciatic Block

Northwestern University·interventional·Posted Jan 10, 2011·Updated Apr 6, 2017

In Brief

A Phase 4 clinical trial evaluating Bupivacaine and Ropivacaine for The Duration of Motor Block May Vary Between 12-36 Hrs. Completed, enrolled 142 participants across 1 site.

Detailed Summary

The duration of motor block for infragluteal parabiceps sciatic nerve block following total knee replacement may vary between 12-36 hrs depending on the amount of local anesthetic given.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThe Duration of Motor Block May Vary Between 12-36 Hrs
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 10, 2011
Enrollment StartNov 1, 2010
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.5 years ago

Interventions

Bupivacainedrug

Varying doses to determine the duration of analgesia

Ropivacainedrug

Varying doses to determine the duration of analgesia